Helixmith’s Chinese product approval, Yuhan’s brand launch, and the schedule for South Korea–U.S. security talks

Helixmith 2026-05-29 announced that Engensis, a gene therapy product transferred under a technology licensing agreement, had received product approval in China. The company disclosed the approval as the acquisition of product approval. According to reports, this is the first case of a drug receiving approval in China through a technology transfer.

Yuhan Corporation 2026-05-28 announced a plan to reach conclusions on technology transfer and joint development within the coming 2 years. The company also disclosed that it was pursuing a package deal. The company said it would disclose the specific partner or terms at a later date.

Yuhan Corporation 2026-05-29 announced the launch of its vitamin-based skincare brand The U. The company said it would target both domestic and overseas markets with the brand. The product lineup consists of skincare products centered on vitamins.

South Korea and the United States 2026-06-02 and 2026-06-03 announced that they would formally begin negotiations in the security field related to nuclear energy and nuclear submarines. The negotiations were reportedly scheduled to address security cooperation issues. The two sides plan to hold meetings centered on the negotiation agenda.

Reports have emerged that some users were deceived by a stock website recently launched in the form of an “Excel disguise.” The site used a format that mimicked an Excel document to provide information. The report called the site fraudulent and urged investors to exercise caution.